DR Horton Inc (DHI · NYSE)

D.R. Horton shares sit at $135.00, down 9.5% over three months and 21.9% below their 52-week high, with the stock trading below all key moving averages ahead of its October 29 earnings report. The company beat estimates in three of its last four quarters, most recently reporting $3.20 versus $2.99 expected, though fiscal Q3 revenue was flat year over year and earnings declined 4.8%. Balance sheet strength remains a bright spot: a current ratio of 9.84, $2.08B in cash, and leverage of 1.7x debt/EBITDA, with the quarter generating $374.7M in free cash flow. Valuation is modest at a 12.82 P/E against an analyst target of $158.31, but margin pressure — gross margin at 21.3% and operating margin at 13.0% — and a 20.7% margin print cited in recent coverage temper the outlook.